PLoS ONE (Jan 2018)

Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).

  • Meng-Chi Lin,
  • Chiao-Zhu Li,
  • Chih-Chuan Hsieh,
  • Kun-Ting Hong,
  • Bon-Jour Lin,
  • Chin Lin,
  • Wen-Chiuan Tsai,
  • Chiao-Hua Lee,
  • Man-Gang Lee,
  • Tzu-Tsao Chung,
  • Chi-Tun Tang,
  • Da-Tong Ju,
  • Hsin-I Ma,
  • Ming-Ying Liu,
  • Yuan-Hao Chen,
  • Dueng-Yuan Hueng

DOI
https://doi.org/10.1371/journal.pone.0207612
Journal volume & issue
Vol. 13, no. 11
p. e0207612

Abstract

Read online

Although proton magnetic resonance spectroscopy (1H-MRS) is a common method for the evaluation of intracranial meningiomas, controversy exists regarding which parameter of 1H-MRS best predicts the histopathological grade of an intracranial meningioma. In this study, we evaluated the results of pre-operative 1H-MRS to identify predictive factors for high-grade intracranial meningioma. Thirteen patients with World Health Organization (WHO) grade II-III meningioma (confirmed by pathology) were defined as high-grade; twenty-two patients with WHO grade I meningioma were defined as low-grade. All patients were evaluated by 1H-MRS before surgery. The relationships between the ratios of metabolites (N-acetylaspartate [NAA], creatine [Cr], and choline [Cho]) and the diagnosis of high-grade meningioma were analyzed. According to Mann-Whitney U test analysis, the Cho/NAA ratio in cases of high-grade meningioma was significantly higher than in cases of low-grade meningioma (6.34 ± 7.90 vs. 1.58 ± 0.77, p<0.05); however, there were no differences in age, Cho/Cr, or NAA/Cr. According to conditional inference tree analysis, the optimal cut-off point for the Cho/NAA ration between high-grade and low-grade meningioma was 2.409 (sensitivity = 61.54%; specificity = 86.36%). This analysis of pre-operative 1H-MRS metabolite ratio demonstrated that the Cho/NAA ratio may provide a simple and practical predictive value for high-grade intracranial meningiomas, and may aid neurosurgeons in efforts to design an appropriate surgical plan and treatment strategy before surgery.